Back

CCL17 as a biomarker of premature atherosclerosis in the early development of systemic lupus erythematosus: insights from the Chinese CSTAR cohorts

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: Inflammation in focus Autoimmune/Chronic Inflammatory Disorders and Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Jiabo Wu

Beijing (China)

5 More presentations in this session

Presentation thumbnail
Association between systemic lupus erythematosus and myocardial infarction subtypes - a matched cohort study in Sweden
Doctor I. Samuelsson (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Similar myocardial infarction characteristics and short-term outcomes in patients with and without inflammatory joint diseases: results from a Nationwide Norwegian study
Doctor E. Ikdahl (Oslo, NO)
Abstract Slides Video
Presentation thumbnail
Antiphospholipid antibodies are associated with subclinical cardiac impairment in patients with SLE
Doctor O. Garza Flores (Monterrey, MX)
Abstract Slides Video
Presentation thumbnail
Carotid intima-media thickness in middle-aged adults with and without rheumatoid arthritis: a case-cohort analysis
Mrs P. Estrada (Sao Paulo, BR)
Abstract Slides Video
Presentation thumbnail
Coronary artery calcium in middle-aged adults with and without rheumatoid arthritis: a case-cohort analysis.
Mrs P. Estrada (Sao Paulo, BR)
Abstract Slides Video

Access the full session

Session thumbnail
Inflammation in focus

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Association of CCL17 with risk of major adverse cardiovascular events: a prospective cohort study
thumbnail
Congress Presentation
Association of proteomic signatures and immunophenotyping profiles with subclinical cardiovascular disease characterised by multimodal imaging in South African systemic lupus erythematosus patients
thumbnail
Congress Presentation
Cardiovascular risk management in systemic autoimmune disorders

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources